← Eichor
Study identifier: NCT06288477 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol

Condition: Vital · Pulpotomy · Techniques  ·  Sponsor: October University for Modern Sciences and Arts

PhaseNA
Planned participants44
Who can joinAll sexes, 4 Years to 9 Years
Healthy volunteersYes

About this study

Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth

This description comes directly from the study's public registry record.

Talk to the study team

Marwa A Salamon, Ph.D  ·  +20 101 655 5055  ·  maasalmon@msa.edu.eg

Marwa A Salmoon, Ph.D  ·  01016555055  ·  maasalmoon@msa.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

MSA UniversityEl-Sheikh Zayed City, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06288477